Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wenzhou Kangning Hospital CoFRA:4WK +3.21%75 EV-to-EBIT is 15.29 as of Aug. 26, 2026, which is 24% below its 10-year median of 20.07. GuruFocus rates FRA:4WK with a GF Score™ of 75/100 and a GF Value™ of €1.36. The stock has 3 warning signs investors should review. Among 479 Healthcare Providers & Services companies, Wenzhou Kangning Hospital Co ranks better than 53.03% on this metric.
The historical rank and industry rank for Wenzhou Kangning Hospital Co's EV-to-EBIT or its related term are showing as below:
FRA:4WK'
s EV-to-EBIT Range Over the Past 10 Years
Min: 10.12 Med: 20.07 Max: 37.25
Current: 15.42
During the past 12 years, the highest EV-to-EBIT of Wenzhou Kangning Hospital Co was 37.25. The lowest was 10.12. And the median was 20.07.
FRA:4WK's EV-to-EBIT is ranked better than 53.03% of 479
companies
in the Healthcare Providers & Services industry
Industry Median: 15.7
vs FRA:4WK: 15.42
Wenzhou Kangning Hospital Co (FRA:4WK) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Wenzhou Kangning Hospital Co's Enterprise Value for the quarter that ended in Jun. 2026 was €145.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Wenzhou Kangning Hospital Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was €11.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wenzhou Kangning Hospital Co EV-to-EBIT Related Terms
Wenzhou Kangning Hospital Co EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Wenzhou Kangning Hospital Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wenzhou Kangning Hospital Co EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wenzhou Kangning Hospital Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Wenzhou Kangning Hospital Co's EV-to-EBIT falls into.
Wenzhou Kangning Hospital Co's current Enterprise Value is €169.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Wenzhou Kangning Hospital Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was €11.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wenzhou Kangning Hospital Co (FRA:4WK) has a EV-to-EBIT of 15.29 as of Aug. 26, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Wenzhou Kangning Hospital Co and its competitors. This is 24% below median its historical median of 20.07. Over the past decade, Wenzhou Kangning Hospital Co's EV-to-EBIT has ranged from 10.12 to 37.25. According to the industry distribution chart, Wenzhou Kangning Hospital Co ranks #225 out of 479 companies in the Healthcare Providers & Services industry, placing it in the top 47%.
Is Wenzhou Kangning Hospital Co's EV-to-EBIT too high?
Wenzhou Kangning Hospital Co's current EV-to-EBIT of 15.29 is 24% below median its 10-year median of 20.07. Over the past 10 years, this metric has ranged from a low of 10.12 to a high of 37.25. The Healthcare Providers & Services industry median EV-to-EBIT is 15.70. Wenzhou Kangning Hospital Co's value of 15.29 is 2.6% below this industry median. Based on the distribution chart, Wenzhou Kangning Hospital Co ranks #225 out of 479 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Wenzhou Kangning Hospital Co has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Wenzhou Kangning Hospital Co's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wenzhou Kangning Hospital Co ranks #225 out of 479 companies for EV-to-EBIT. This puts Wenzhou Kangning Hospital Co in the upper half of its industry. The industry median EV-to-EBIT is 15.70. Wenzhou Kangning Hospital Co's value of 15.29 is 2.6% below this benchmark. Historically, Wenzhou Kangning Hospital Co's own EV-to-EBIT has ranged from 10.12 to 37.25 over the past decade. While the company's 10-year median is 20.07 vs. the industry median of 15.70, Wenzhou Kangning Hospital Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.70, based on 479 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wenzhou Kangning Hospital Co's current EV-to-EBIT of 15.29 is 2.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Wenzhou Kangning Hospital Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wenzhou Kangning Hospital Co's current EV-to-EBIT is 15.29, which is 24% below median its own 10-year median of 20.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wenzhou Kangning Hospital Co stock overvalued right now?
Wenzhou Kangning Hospital Co (FRA:4WK) has a current EV-to-EBIT of 15.29. The stock's GF Value™ is €1.36, compared to a current price of €0.97 — trading 29% below its estimated fair value. The current EV-to-EBIT is 15.29, which is 24% below median its 10-year median of 20.07 and 2.6% below the Healthcare Providers & Services industry median of 15.70. Wenzhou Kangning Hospital Co's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Wenzhou Kangning Hospital Co (FRA:4WK), the current EV-to-EBIT is 15.29 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wenzhou Kangning Hospital Co (FRA:4WK) Overvalued in 2026?
Based on GuruFocus' analysis, Wenzhou Kangning Hospital Co stock appears to be undervalued.
The current stock price of €0.97 is trading 29% below its estimated GF Value™ of €1.36.
Key valuation signals for FRA:4WK:
EV-to-EBIT: 15.29 (24% below median its 10-year median of 20.07)
GF Value™: €1.36 vs. price of €0.97 (29% below fair value)
Industry Position: 2.6% below the Healthcare Providers & Services median (#225 of 479)
No single metric tells the full story. See the FRA:4WK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wenzhou Kangning Hospital Co Ltd is engaged in operating a network of healthcare facilities that focus on providing psychiatric specialty care and elderly rehabilitation service across various regions in China. It derives revenue from operating its owned hospitals consists of fees charged for outpatient visits and inpatient services at the group's various hospitals, which can be divided into treatment and general healthcare services and pharmaceutical sales, as well as variable considerations for medical services provided by the group, mainly including medical insurance settlement differences.
75GF Score
Get the complete analysis for FRA:4WK
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4WK has been successfully added to your 
